New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting

Spergel, J. M.; Aceves, S. S.; Kliewer, K.; Gonsalves, N.; Chehade, M.; Wechsler, J. B.; Groetch, M.; Friedlander, J.; Dellon, E. S.; Book, W.; Hirano, I.; Muir, A. B.; Cianferoni, A.; Spencer, L.; Liacouras, C. A.; Cheng, E.; Kottyan, L.; Wen, T.; Platts-Mills, T.; Rothenberg, M. E.

J Allergy Clin Immunol. 2018 May 29; 142(1):48-53

Abstract

The Consortium of Eosinophilic Gastrointestinal Diseases and the International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the recent 2018 Annual Meeting of the American Academy of Allergy, Asthma & Immunology, which was coupled for the first time with the World Allergy Organization meeting to create an international platform. The symposium featured experts in many facets of eosinophilic gastrointestinal diseases, including allergy, immunology, gastroenterology, pathology, and nutrition, and was a well-attended event. The basic science, genetics, cellular immunology, and clinical features of the diseases, with a focus on epithelial, eosinophil, and mast cell responses, as well as current and emerging treatment options, were reviewed. Here we briefly review some of the highlights of the material presented at the meeting.

Read More on PubMed